Related Experiment Video
Updated: Jan 31, 2026

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
Effectiveness of pharmaceutical interventions for meibomian gland dysfunction: An evidence-based review of clinical
Pauline Khoo1, Kenneth G-J Ooi1, Stephanie Watson1
1Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.
Abstract:
Meibomian gland dysfunction is one of the most common ocular disorders encountered by ophthalmologists and is the leading cause of evaporative dry eye. The disease causes significant morbidity in the population such that patients seek treatment. Multiple clinical studies on pharmacological and mechanical interventions for the treatment of meibomian gland dysfunction have been evaluated. However, there is limited comparative clinical evidence for the effectiveness of these interventions. This review paper aims to report the clinical evidence for pharmaceutical interventions for meibomian gland dysfunction in order to guide clinicians in the management of the disease.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
The Evidence for Evolution
Statistical Software for Data Analysis and Clinical Trials
Pharmaceutical Equivalents

